Method for the Treatment or prevention of Pain and inflammatory processes and diseases, Pharmaceutical composition for use in the packaging, in the proceedings

摘要

To treat or prevent ignition process and diseases in dogs caused by conductive oxygen-2 cycle activity (COX-2), and to reduce or eliminate adverse side effects related to simultaneous inhibition of oxygen-1 cycle activity (COX-1), By selectively inhibiting the activity of COX-2 in COX-1 activity, wherein the selective proportion of COX-2: COX-1 is at least 3:1, according to the prebiotic inhibition level measured in whole blood;the inhibitor is a member selected from the group of anti-inflammatory compounds consisting essentially of derivatives of salicylic acid; dep-aminophen ol derivatives; indole and idenoacetic acids, heteroaryl acetic acids; arylpropionic acids; anthranilic acids; enolic acids; and alkanones; the inhibitor, in particular, is composed of elenantiomer (-) (S) of 6-chloro-alpha-methyl-9H-carbazol-2-acetic acid.